垂体腺瘤,Pituitary adenoma
1)Pituitary adenoma垂体腺瘤
1.Relationship between the expression of uPA、PAI-1、bFGF、 microvessel density and the invasiveness of human pituitary adenoma;uPA、PAI-1、bFGF的表达和MVD计数与垂体腺瘤侵袭性的关系
2.Anatomical observation of operative approach of pituitary adenoma;垂体腺瘤手术入路的解剖学观察
3.Metrological analysis of literature on pituitary adenomas reported during period 1994- in China;垂体腺瘤1994～国内发表文献计量分析
英文短句/例句
1.Diagnosis and Treatment of Pituitary Adenomas (Analysis of 120 Patients of Pituitary Adenomas);垂体腺瘤诊断与治疗（附128例垂体腺瘤病例分析）
2.The Relationship between Invasiveness and Expression of Galectin-3 and Ki-67 in Human Pituitary Adenomas;Galectin-3、Ki-67在垂体腺瘤中的表达及与垂体腺瘤侵袭性的关系
3.Relations between Expression of Pituitary Tumor Transforming Gene (PTTG), MatrixetalloProteinase-2, 9(MMP-2, MMP-9) and Invasion in Pituitary Adenomas;垂体腺瘤中的PTTG、MMP-2、MMP-9的表达与垂体腺瘤侵袭性的关系
4.Low-Field MRI Shape of Pituitary Change for Diagnosis Value of Pituitary Adenoma低场MRI垂体形态改变对垂体腺瘤的诊断价值
5.The circumscribed mass lesion present here in the sella turcica is a pituitary adenoma.蝶鞍内的边界清楚的肿块为垂体腺瘤。
6.Pituitary adenomas in childhood and adolescence:analysis of 23 cases儿童和青春期垂体腺瘤（附23例报告）
7.Clinical and Radiologic Studies on Invasive Pituitary Adenomas;侵袭性垂体腺瘤的影像学与实验研究
8.Expression and the Significance of CD105 in Human Pituitary Adenomas;CD105在垂体腺瘤中的表达及其意义
9.Ocular Presentation of Pituitary Adenoma and the Analysis of the Correlation with MRI Feature;垂体腺瘤眼部表现及与MRI相关性分析
10.Related Study between the Expression of CD105 and VEGF in Pituitary Adenomas;垂体腺瘤中CD105表达与VEGF的相关研究
11.A Direct Transnasal Transsphenoidal Approach for Pituitary Adenomas;单鼻孔直接经蝶垂体腺瘤切除术初探
12.The Diagnosis Criteria of the Invasive Pituitary Adenoma by MRI and the Evalution;侵袭性垂体腺瘤MRI诊断标准及其评价
13.The Retrospective Study of 526 Pituitary Tumor Data in the Post Operation;526例垂体腺瘤临床资料的回顾性分析
14.Study on Therapeutic Potential of RNAi Targeting Survivin in Pituitary Tumor靶向Survivin的RNAi治疗垂体腺瘤的研究
15.Expressions and Their Significance of HIF-1a and VEGF in Pituitary AdenomasHIF-1α和VEGF在垂体腺瘤中的表达和意义
16.The study on expression XIAP,caspase-3 and smac in invasive pituitary adenomas侵袭性垂体腺瘤smac,XIAP,caspase-3的表达
17.The Current Study on MicroRNAs in Pituitary Adenoma垂体腺瘤相关microRNAs的研究进展
18.The pathologial change and an erroneous diagnosis in the eyes of 37 cases with pituitary adenomas垂体腺瘤37例眼部改变及误诊分析
相关短句/例句
Pituitary adenomas垂体腺瘤
1.The expresion and significance of peroxisome proliferator-activated receptor-γ (PPAR-γ) in pituitary adenomas;PPARγ在垂体腺瘤组织中的表达及意义
2.Relationship between p53,bFGF and MVD expression with invasiveness of pituitary adenomas;p53、bFGF和MVD的表达与垂体腺瘤侵袭性的关系
3.Ocular presentations of pituitary adenomas and correlation with MRI features in 200 eyes;垂体腺瘤200例眼部表现与MRI特点的相关性分析
3)pituitary tumor垂体腺瘤
1.The expression of PTEN protein inpituitary tumor and its significance;垂体腺瘤中PTEN蛋白的表达及其临床意义
2.Expression of estrogen receptor in human plurihormonalpituitary tumor;雌激素受体在人类多激素型垂体腺瘤中的表达
3.Objective To examine the expression of estrogen receptor(ER) in different hormone-producingpituitary tumors in order to study the relationship between the specific hormone-secreting adenoma cells and the ER-immunoreactive tumorous pituitary cells.目的检测雌激素受体(estrogenreceptor,ER)在人类不同类型激素垂体腺瘤中的表达,探讨垂体腺瘤中分泌不同类型激素的腺瘤细胞与ER免疫组化阳性细胞之间的关系。
4)hypophysis gland tumor垂体腺肿瘤
5)ACTH-secreting pituitary adenoma垂体ACTH腺瘤
1.Objective To study the clinical characteristics and treatment ofACTH-secreting pituitary adenoma.方法回顾性分析从1月至3月在我院接受治疗的25例垂体ACTH腺瘤患者的临床特点、治疗经过及预后。
6)Pituitary microadenoma垂体微腺瘤
1.MRI diagnosis value of dynamic contrast enhancement and FFE sequence to pituitary microadenomas;MRI动态增强及FFE序列在垂体微腺瘤诊断中的作用
2.Resection of pituitary microadenoma by transnasal transsphenoidal approach(report of 68 cases);经单鼻孔蝶窦入路垂体微腺瘤切除术(附68例报告)
3.ConclusionPituitary microadenoma treated by micro-operation through all removed add extent-removed can improve the effectiveness ratio.目的分析垂体微腺瘤的显微手术治疗效果。
延伸阅读
垂体腺瘤垂体腺瘤pituitaryadenoma起源于垂体前叶细胞的腺瘤。病因不明，可能与垂体细胞本身的缺陷或下丘脑激素分泌功能紊乱有关。垂体肿瘤约占颅内肿瘤的10％，多见于20～50岁者，是垂体前叶功能亢进或低减的重要原因之一。分类①按肿瘤大小分，小于10毫米者为微腺瘤；大于10毫米者为大腺瘤。②按细胞染色及形态可分为嗜酸性、嗜碱性、嫌色性及混合性腺瘤。③按分泌激素的功能和种类，可分为功能性或无功能性腺瘤，以及某种激素分泌瘤。④按性质可分为良性或恶性，以良性者为多见。临床表现与患者的性别、年龄、肿瘤大小和扩展方向及分泌激素的类型有关，包括以下4组症状：①垂体瘤分泌激素过多引起的症状和体征，常见者为肢端肥大症、库兴氏病及催乳激素瘤。②垂体本身受压症群，主要是垂体促激素分泌减少，一般首先影响生长激素GH，其次为促黄体素、促卵泡素，最后为促肾上腺皮质激素、促甲状腺素。少数可伴有尿崩症。③垂体周围组织受压症群，包括头痛、视力下降、视野缺损、下丘脑综合征、海绵窦症群和脑脊液鼻漏等。④垂体卒中，指垂体腺瘤和/或垂体本身梗死、坏死或出血，临床上可迅速出现压迫症状及脑膜刺激症状，垂体功能亢进的临床表现可消失或减轻，甚至出现垂体前叶功能低减。诊断综合临床表现、血中垂体及靶腺激素水平、下丘脑-垂体-靶腺轴功能测定以及影像学和视野检查结果进行诊断和鉴别诊断。治疗根据肿瘤的性质、大小，病情进展速度等情况而定。主要有以下几种方法：①手术治疗，经蝶垂体腺瘤切除术治愈率达1/2～2/3；向鞍上扩展的大腺瘤可行经额手术。②垂体放射治疗，外照射有深度X线、60Co射线、重粒子（α粒子束、质子束)照射；内照射是将核素如198Au或90Yb经蝶植入垂体窝。③药物治疗，如用溴隐亭等多巴胺激动剂治疗垂体催乳激瘤，用生长抑素激动剂治疗肢端肥大症等。
